Clinical evaluation of rosoxacin for the treatment of chancroid.

One hundred seven men with Haemophilus ducreyi-positive chancroid were assigned to receive 300 mg of rosoxacin as a single dose or 150 mg twice daily for 3 days. Ulcers and buboes were followed clinically and bacteriologically for 1 month. Of 40 evaluable males on the 3-day regimen, 38 (95%) were cu...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Haase, D A, Ndinya-Achola, J O, Nash, R A, D'Costa, L J, Hazlett, D, Lubwama, S, Nsanze, H, Ronald, A R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1986
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176431/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3489439/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.1.39
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!